BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7349263)

  • 1. [Clinical and polygraphic evaluation of the effects of metoprolol and labetalol in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Boll Soc Ital Cardiol; 1981; 26(11):1909-16. PubMed ID: 7349263
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical, ergometric and polygraphic evaluation of the effects of metoprolol and labetalol administration in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Minerva Med; 1982 Apr; 73(14):845-9. PubMed ID: 7070696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension in general practice: a comparative study of labetalol and metoprolol (+/- prazosin) in general practice.
    Piterman L
    Aust Fam Physician; 1981 Jul; 10(7):579-83. PubMed ID: 7283872
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of metroprolol and labetalol. Antihypertensive activity at rest and during exertion and effect on some noninvasive parameters of cardiovascular function].
    Demarchi PG; Mancini A; Brignole M; Astengo D; Bertulla A
    Minerva Cardioangiol; 1981 Dec; 29(12):719-28. PubMed ID: 7038536
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ; Louis WJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of systolic time intervals in the evaluation of antihypertensive treatment with metoprolol, labetalol and prazosin.
    Buch J; Rasmussen S
    Cor Vasa; 1983; 25(5):358-66. PubMed ID: 6653128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of labetalol in essential hypertension. Effects of long-term treatment in conditions of rest and stress].
    Rossi A; Ziacchi V; Lomanto B
    Minerva Cardioangiol; 1980 Sep; 28(9):637-44. PubMed ID: 7007921
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effects of metoprolol on systolic times in patients with systemic arterial hypertension. Polygraphic study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Minerva Med; 1982 Jan; 73(1-2):71-5. PubMed ID: 7058006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Labetalol: a field study in essential hypertension (author's transl)].
    Greminger P; Minder F; Schärer HU
    Schweiz Rundsch Med Prax; 1982 Feb; 71(8):332-6. PubMed ID: 7041108
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of the combination of chlorthalidone with verapamil and metoprolol in arterial hypertension: evaluation by cycloergometrics].
    Candau LA; Pereira LS; Scherr C
    Arq Bras Cardiol; 1981 Aug; 37(2):133-8. PubMed ID: 6753801
    [No Abstract]   [Full Text] [Related]  

  • 11. [Open clinical trial of labetalol in ambulatory patients with arterial hypertension].
    Baratta L; Florio P; Guerrieri P; Lanciotti G; Mastrocola C; Petrosillo N; Scarfò G; Avella A
    Clin Ter; 1981 Oct; 99(2):139-47. PubMed ID: 7032831
    [No Abstract]   [Full Text] [Related]  

  • 12. [Labetalol in the treatment of arterial hypertension. A Brazilian multicenter study].
    Benchimol AB; Sbissa AS; Benchimol CB; Saad EA; Barbosa ET; Albanesi Filho FM; Pillegi F; da Cunha GP; Maranhão MF; Batlouni M; Schlesinger P; Duprat R; Maciel R
    Arq Bras Cardiol; 1982 May; 38(5):421-7. PubMed ID: 6762868
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension].
    Palla R; Bionda A; Carmassi F; Giusti R; Marchitiello M
    Recenti Prog Med; 1980 Nov; 69(5):551-5. PubMed ID: 7465989
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic effects of labetalol in patients with acute myocardial infarct and systemic arterial hypertension].
    Cantelli I; Lombardi G; Naccarella F; Pavesi PC; Bracchetti D
    G Ital Cardiol; 1981; 11(1):110-8. PubMed ID: 7239092
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of metoprolol and of the combination of metoprolol and hydrochlorothiazide arterial hypertension patients].
    Strano A; Novo S; Salvia A
    Boll Soc Ital Cardiol; 1980; 25(4):333-45. PubMed ID: 7284139
    [No Abstract]   [Full Text] [Related]  

  • 16. [Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension].
    Cybulska I; Sznajderman M; Brym E; Czerniewska E
    Pol Tyg Lek; 1981 Aug; 36(34):1309-11. PubMed ID: 7038638
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of prolonged treatment with labetalol on renal function and on water and saline metabolism in essential and reno-parenchymal hypertension].
    Valvo E; Tessitore N; Previato G; Lupo A; Lo Schiavo C; Tornieri G; Maschio G
    Minerva Nefrol; 1979; 26(1):1-3. PubMed ID: 471316
    [No Abstract]   [Full Text] [Related]  

  • 18. [Atenolol and metoprolol in the treatment of slight to moderate hypertension. A comparative study].
    Rasmussen S; Arnung K; Eskildsen PC; Nielsen PE
    Ugeskr Laeger; 1982 Dec; 144(51):2823-6. PubMed ID: 6762745
    [No Abstract]   [Full Text] [Related]  

  • 19. [Monotherapy of uncomplicated essential hypertension with metoprolol].
    Mahlke R; Kühns K
    Med Welt; 1980 Feb; 31(9):333-5. PubMed ID: 7374428
    [No Abstract]   [Full Text] [Related]  

  • 20. A five-year study of labetalol in hypertension.
    Kane J; Gregg I; Stephens MD
    Practitioner; 1981 Jan; 225(1351):97-8, 100. PubMed ID: 7220466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.